Clinical application of the GLOBE and United Kingdom-primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis.

Carbone, Marco; Harms, Maren H; Lammers, Willem J; Marmon, Tonya; Pencek, Richard; MacConell, Leigh; Shapiro, David; Jones, David E; Mells, George F; Hansen, Bettina E

Carbone, Marco; Harms, Maren H; Lammers, Willem J; Marmon, Tonya; Pencek, Richard; MacConell, Leigh; Shapiro, David; Jones, David E; Mells, George F; Hansen, Bettina E.

Afiliación

Carbone M; Academic Department of Medical Genetics University of Cambridge Cambridge United Kingdom.
Harms MH; Division of Gastroenterology University of Milan-Bicocca Milan Italy.
Lammers WJ; Department of Gastroenterology and Hepatology Erasmus University Medical Center Rotterdam the Netherlands.
Marmon T; Department of Gastroenterology and Hepatology Erasmus University Medical Center Rotterdam the Netherlands.
Pencek R; Intercept Pharmaceutical, Inc. San Diego CA.
MacConell L; Intercept Pharmaceutical, Inc. San Diego CA.
Shapiro D; Intercept Pharmaceutical, Inc. San Diego CA.
Jones DE; Intercept Pharmaceutical, Inc. San Diego CA.
Mells GF; Institute of Cellular Medicine Newcastle University Newcastle United Kingdom.
Hansen BE; Academic Department of Medical Genetics University of Cambridge Cambridge United Kingdom.

Hepatol Commun ; 2(6): 683-692, 2018 Jun.

Article en En | MEDLINE | ID: mdl-29881820

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Commun Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google